(RTTNews) - European shares drifted lower on Wednesday, with renewed Middle East tensions and France's deepening fiscal crisis keeping investors on edge.
(RTTNews) - Nurix Therapeutics, Inc. (NRIX), a clinical-stage biopharmaceutical company, announced on Wednesday that it has enrolled the first patient in a Phase 1b/2 study evaluating bexobrutideg in combination with venetoclax in chronic lymphocytic leukemia/small lymphocytic ly
(RTTNews) - Asian stocks ended broadly lower in cautious trade on Wednesday as oil prices climbed and yields rebounded on fears Iran is stepping up attacks on tankers in the Strait of Hormuz.
(RTTNews) - Repligen Corp. (RGEN), a life sciences company, announced that it has completed the previously announced acquisition of BioLife Solutions, Inc. (BLFS), a developer and supplier of cell processing tools and services for the cell and gene therapy market.